Somaxon Seeks Partner For Silenor Insomnia Drug Switch
This article was originally published in The Tan Sheet
Executive Summary
P&G’s exit from the switch picture adds “salt to a wound left by” Somaxon’s unsuccessful prescription Silenor launch in 2010, Jeffries analysts note. Somaxon recently laid off 75% of its sales staff and drastically cut marketing to minimize its cash burn rate, which far outpaced initial sales.